TAVR Firm JenaValve Nabs Boston Sci Exec As CEO
This article was originally published in The Gray Sheet
Executive Summary
Victoria Carr-Brendel, who was running Boston Scientific’s Bayer Interventional business, is the new CEO of transcatheter aortic valve company JenaValve. TAVR startup competitor, Direct Flow Medical, also recently hired a new CEO with large-company medtech pedigree.